Literature DB >> 8335020

Antibody deficiency and isolated growth hormone deficiency in a girl with Mulibrey nanism.

A Haraldsson1, C J van der Burgt, C M Weemaes, B Otten, J A Bakkeren, G B Stoelinga.   

Abstract

A combination of humoral immunodeficiency and isolated growth hormone deficiency was observed in a girl with Mulibrey nanism. The humoral immunodeficiency consisted of subnormal concentration of serum IgG, in particular IgG2 and IgG4, and low concentration of serum IgM. Serum IgA and IgD were elevated, IgE was absent. Antibody response in vivo was very low or absent and opsonization in vitro was defective. Total B-cell number was low. In addition, the serum kappa/lambda light chain ratios within the immunoglobulin classes G, A, and M were abnormal. The defective antibody response may be linked to the abnormal kappa/lambda light chain ratios. Endocrine functions were normal except for isolated growth hormone deficiency. Therapy with human growth hormone resulted in increased growth velocity but did not improve humoral immune functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335020     DOI: 10.1007/bf01955061

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Determination of kappa and lambda light chains in serum immunoglobulins G, A and M.

Authors:  A Haraldsson; M J Kock-Jansen; M Jaminon; P B van Eck-Arts; T de Boo; C M Weemaes; J A Bakkeren
Journal:  Ann Clin Biochem       Date:  1991-09       Impact factor: 2.057

2.  Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification, and characterization.

Authors:  W Kiess; O Butenandt
Journal:  J Clin Endocrinol Metab       Date:  1985-04       Impact factor: 5.958

3.  Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes. Characterization of the interaction and a sensitive radioreceptor assay.

Authors:  M A Lesniak; P Gorden; J Roth; J R Gavin
Journal:  J Biol Chem       Date:  1974-03-25       Impact factor: 5.157

4.  Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse.

Authors:  R J Duquesnoy
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

5.  The efficacy of growth hormone in different types of growth failure. An analysis of 101 cases.

Authors:  H L Lenko; S Leisti; J Perheentupa
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

6.  Constrictive pericarditis with dwarfism in two siblings (mulibrey nanism).

Authors:  G R Cumming; D Kerr; C C Ferguson
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

7.  Antibody responses in vivo in chromosome instability syndromes with immunodeficiency.

Authors:  C M Weemaes; T H The; P J van Munster; J A Bakkeren
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

8.  Molecular analysis of X-linked agammaglobulinemia with growth hormone deficiency.

Authors:  M E Conley; A W Burks; H G Herrod; J M Puck
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

9.  [On the isolation and determination of immunoglobulin-A (IgA)].

Authors:  P J van Munster; G B Stoelinga
Journal:  Maandschr Kindergeneeskd       Date:  1965-11

10.  Immunological and endocrinological response to growth hormone therapy in short children.

Authors:  M Bozzola; R Maccario; M Cisternino; M de Amici; A Valtorta; A Moretta; I Biscaldi; R M Schimpff
Journal:  Acta Paediatr Scand       Date:  1988-09
View more
  3 in total

1.  Assignment of the mulibrey nanism gene to 17q by linkage and linkage-disequilibrium analysis.

Authors:  K Avela; M Lipsanen-Nyman; J Perheentupa; C Wallgren-Pettersson; S Marchand; S Fauré; P Sistonen; A de la Chapelle; A E Lehesjoki
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

2.  Mulibrey nanism: clinical features and diagnostic criteria.

Authors:  N Karlberg; H Jalanko; J Perheentupa; M Lipsanen-Nyman
Journal:  J Med Genet       Date:  2004-02       Impact factor: 6.318

3.  CD4+ T Cell Defects in a Mulibrey Patient With Specific TRIM37 Mutations.

Authors:  Sara Bruzzaniti; Emilia Cirillo; Rosaria Prencipe; Giuliana Giardino; Maria Teresa Lepore; Federica Garziano; Francesco Perna; Claudio Procaccini; Luigi Mascolo; Cristina Pagano; Valentina Fattorusso; Enza Mozzillo; Maurizio Bifulco; Giuseppe Matarese; Adriana Franzese; Claudio Pignata; Mario Galgani
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.